Irinotecan Hydrochloride 55150-0354-01

Package NDC

55150-0354-01

Manufacturer: Eugia Us Llc
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: February 11, 2020
Listing Expires: December 31, 2026
Application: ANDA213278

Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Irinotecan Hydrochloride	20 mg/mL

Drug Class

Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]

Selected Package

55150-0354-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-354-01) / 15 mL in 1 VIAL, SINGLE-DOSE